Vitamin C and Charcot–Marie–Tooth 1A: Pharmacokinetic considerations

Charcot–Marie–Tooth 1A disease (CMT1A) is a disease for which no drug treatments are available. In 2004, it was reported that ascorbic acid reduced the severity of neuropathy in transgenic mice overexpressing PMP22, an animal model of human CMT1A, compared with untreated mice. Based on those results...

Descripción completa

Detalles Bibliográficos
Autores principales: Visioli, F., Reilly, M.M., Rimoldi, M., Solari, A., Pareyson, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603168/
https://www.ncbi.nlm.nih.gov/pubmed/23525455
http://dx.doi.org/10.1016/j.phanu.2012.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603168/
https://www.ncbi.nlm.nih.gov/pubmed/23525455
http://dx.doi.org/10.1016/j.phanu.2012.10.001

Ejemplares similares